MA26505A1 - Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number: MA26505A1
Authority: MA; Morocco
Prior art keywords: methylerythromycin; derivatives; preparation; pharmaceutical compositions; compositions containing
Prior art date: 1997-06-11

Application number

MA25105A

Other languages

English (en)

Inventor

Wu Yong-Jin

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-11

Filing date

1998-06-10

Publication date

2004-12-20

1998-06-10 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-12-20 Publication of MA26505A1 publication Critical patent/MA26505A1/fr

Links

AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Tropical Medicine & Parasitology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

MA25105A 1997-06-11 1998-06-10 Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant MA26505A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US4934997P	1997-06-11	1997-06-11

Publications (1)

Publication Number	Publication Date
MA26505A1 true MA26505A1 (fr)	2004-12-20

Family

ID=21959341

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25105A MA26505A1 (fr)	1997-06-11	1998-06-10	Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (31)

Country	Link
EP (1)	EP0988308A1 (fr)
JP (1)	JP2000513026A (fr)
KR (1)	KR20010013660A (fr)
CN (1)	CN1259135A (fr)
AP (1)	AP9801253A0 (fr)
AR (1)	AR012244A1 (fr)
AU (1)	AU7226798A (fr)
BG (1)	BG103947A (fr)
BR (1)	BR9810021A (fr)
CA (1)	CA2293335A1 (fr)
CO (1)	CO4940506A1 (fr)
CZ (1)	CZ9904388A3 (fr)
EA (1)	EA199901016A1 (fr)
GT (1)	GT199800074A (fr)
HN (1)	HN1998000073A (fr)
HR (1)	HRP980316A2 (fr)
HU (1)	HUP0002252A3 (fr)
ID (1)	ID24529A (fr)
IL (1)	IL132767A0 (fr)
IS (1)	IS5251A (fr)
MA (1)	MA26505A1 (fr)
NO (1)	NO996108L (fr)
OA (1)	OA11225A (fr)
PA (1)	PA8451801A1 (fr)
PE (1)	PE79899A1 (fr)
PL (1)	PL337606A1 (fr)
TN (1)	TNSN98083A1 (fr)
TR (1)	TR199902995T2 (fr)
TW (1)	TW448174B (fr)
WO (1)	WO1998056800A1 (fr)
ZA (1)	ZA985018B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HN1998000159A (es) *	1997-10-29	1999-02-09	Monsanto Co	Derivados de 9- amino - 3 ceto eritromicina
WO2000017218A1 (fr) *	1998-09-22	2000-03-30	Pfizer Products Inc.	Antibiotiques carbamates et carbazates cetolides
FR2786188B1 (fr) *	1998-11-24	2002-10-31	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en)	1998-12-02	2001-07-10	Pfizer Inc.	Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (fr) *	1998-12-10	2006-11-02	Pfizer Products Inc.	Dérivés anitiobiotiques de Carbamate et de Carbazate Kètolides
US6284732B1 (en) *	1998-12-18	2001-09-04	Bio-Rad Laboratories, Inc.	Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
AU775637B2 (en) *	1999-04-16	2004-08-12	Kosan Biosciences, Inc.	Macrolide antiinfective agents
EE200100613A (et)	1999-05-24	2003-02-17	Pfizer Products Inc.	13-metüülerütromütsiini derivaadid
ATE250076T1 (de) *	1999-06-07	2003-10-15	Abbott Lab	6-o-carbamat ketolide derivate
ID27331A (id) *	1999-09-29	2001-03-29	Pfizer Prod Inc	Pembuatan antibiotik-antibiotik ketolida karbamat
EP1114826A3 (fr) *	1999-12-29	2001-10-31	Pfizer Products Inc.	Macrolides antibactériennes et prokinétiques
EP1439186A3 (fr) *	1999-12-29	2004-11-03	Pfizer Products Inc.	Intermédiaires pour macrolides antibactérielles et procinétiques
US6946446B2 (en)	2000-02-24	2005-09-20	Abbott Laboratories	Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en)	2000-07-05	2002-06-11	Pfizer Inc.	Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (fr) *	2002-04-25	2003-11-06	Abbott Laboratories	Antibacteriens 9-oxime macrolide
US7091196B2 (en)	2002-09-26	2006-08-15	Rib-X Pharmaceuticals, Inc.	Bifunctional heterocyclic compounds and methods of making and using same
US7601695B2 (en) *	2003-03-10	2009-10-13	Optimer Pharmaceuticals, Inc.	Antibacterial agents
EP2716647A3 (fr)	2004-02-27	2014-08-20	Rib-X Pharmaceuticals, Inc.	Composes Macrocycliques Et Leurs Procedes De Fabrication Et D'utilisation
AU2008316830B2 (en)	2007-10-25	2016-03-17	Cempra Pharmaceuticals, Inc.	Process for the preparation of macrolide antibacterial agents
CN107854477A (zh)	2008-10-24	2018-03-30	森普拉制药公司	使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en)	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
US9480679B2 (en)	2009-09-10	2016-11-01	Cempra Pharmaceuticals, Inc.	Methods for treating malaria, tuberculosis and MAC diseases
CN102146085B (zh) *	2010-02-09	2014-03-26	北京理工大学	一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
HRP20160168T1 (hr)	2010-03-22	2016-03-25	Cempra Pharmaceuticals Inc	Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt)	2010-05-20	2016-08-02	Cempra Pharmaceuticals Inc	processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko)	2010-09-10	2013-11-04	셈프라 파마슈티컬스, 인크.	질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (fr)	2012-03-27	2013-10-03	Cempra Pharmaceuticals, Inc.	Formulations parentérales pour l'administration d'antibiotiques macrolides
WO2014152326A1 (fr)	2013-03-14	2014-09-25	Cempra Pharmaceuticals, Inc.	Procédés pour traiter des maladies respiratoires et formulations pour la mise en œuvre de ceux-ci
AU2014233240B2 (en)	2013-03-15	2018-08-09	Cempra Pharmaceuticals, Inc.	Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) *	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
FR2718450B1 (fr) *	1994-04-08	1997-01-10	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

1998
- 1998-05-15 KR KR1019997011672A patent/KR20010013660A/ko not_active Ceased
- 1998-05-15 PL PL98337606A patent/PL337606A1/xx unknown
- 1998-05-15 HU HU0002252A patent/HUP0002252A3/hu unknown
- 1998-05-15 WO PCT/IB1998/000741 patent/WO1998056800A1/fr not_active Ceased
- 1998-05-15 CZ CZ19994388A patent/CZ9904388A3/cs unknown
- 1998-05-15 EA EA199901016A patent/EA199901016A1/ru unknown
- 1998-05-15 TR TR1999/02995T patent/TR199902995T2/xx unknown
- 1998-05-15 AU AU72267/98A patent/AU7226798A/en not_active Abandoned
- 1998-05-15 BR BR9810021-1A patent/BR9810021A/pt not_active IP Right Cessation
- 1998-05-15 CA CA002293335A patent/CA2293335A1/fr not_active Abandoned
- 1998-05-15 EP EP98919394A patent/EP0988308A1/fr not_active Withdrawn
- 1998-05-15 JP JP11501928A patent/JP2000513026A/ja active Pending
- 1998-05-15 IL IL13276798A patent/IL132767A0/xx unknown
- 1998-05-15 ID IDW991570A patent/ID24529A/id unknown
- 1998-05-15 CN CN98805848A patent/CN1259135A/zh active Pending
- 1998-05-19 HN HN1998000073A patent/HN1998000073A/es unknown
- 1998-05-21 PA PA19988451801A patent/PA8451801A1/es unknown
- 1998-06-04 AP APAP/P/1998/001253A patent/AP9801253A0/en unknown
- 1998-06-05 GT GT199800074A patent/GT199800074A/es unknown
- 1998-06-08 PE PE1998000470A patent/PE79899A1/es not_active Application Discontinuation
- 1998-06-08 TW TW087109086A patent/TW448174B/zh active
- 1998-06-09 AR ARP980102703A patent/AR012244A1/es unknown
- 1998-06-10 ZA ZA9805018A patent/ZA985018B/xx unknown
- 1998-06-10 MA MA25105A patent/MA26505A1/fr unknown
- 1998-06-10 TN TNTNSN98083A patent/TNSN98083A1/fr unknown
- 1998-06-11 HR HR60/049,349A patent/HRP980316A2/hr not_active Application Discontinuation
- 1998-06-11 CO CO98033538A patent/CO4940506A1/es unknown
1999
- 1999-11-16 IS IS5251A patent/IS5251A/is unknown
- 1999-12-03 BG BG103947A patent/BG103947A/xx unknown
- 1999-12-03 OA OA9900269A patent/OA11225A/en unknown
- 1999-12-10 NO NO996108A patent/NO996108L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0002252A2 (hu)	2000-12-28
AP9801253A0 (en)	1999-12-04
CO4940506A1 (es)	2000-07-24
BR9810021A (pt)	2000-09-19
JP2000513026A (ja)	2000-10-03
GT199800074A (es)	1999-11-27
HUP0002252A3 (en)	2002-01-28
HRP980316A2 (en)	1999-04-30
HN1998000073A (es)	1999-01-08
CZ9904388A3 (cs)	2002-10-16
KR20010013660A (ko)	2001-02-26
NO996108L (no)	2000-02-10
EA199901016A1 (ru)	2000-06-26
OA11225A (en)	2003-07-17
WO1998056800A1 (fr)	1998-12-17
IL132767A0 (en)	2001-03-19
CN1259135A (zh)	2000-07-05
TW448174B (en)	2001-08-01
AU7226798A (en)	1998-12-30
AR012244A1 (es)	2000-09-27
CA2293335A1 (fr)	1998-12-17
ZA985018B (en)	1999-12-10
TR199902995T2 (xx)	2000-02-21
PE79899A1 (es)	1999-08-25
NO996108D0 (no)	1999-12-10
TNSN98083A1 (fr)	2005-03-15
ID24529A (id)	2000-07-20
PA8451801A1 (es)	2000-05-24
BG103947A (en)	2000-07-31
IS5251A (is)	1999-11-16
PL337606A1 (en)	2000-08-28
EP0988308A1 (fr)	2000-03-29

Similar Documents

Publication	Publication Date	Title
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26479A1 (fr)	2004-12-20	Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26468A1 (fr)	2004-12-20	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26424A1 (fr)	2004-12-20	Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26433A1 (fr)	2004-12-20	Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26558A1 (fr)	2004-12-20	Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2735777B1 (fr)	1997-09-12	Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26680A1 (fr)	2004-12-20	Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26499A1 (fr)	2004-12-20	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26687A1 (fr)	2004-12-20	4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26686A1 (fr)	2004-12-20	Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26425A1 (fr)	2004-12-20	Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26559A1 (fr)	2004-12-20	Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26432A1 (fr)	2004-12-20	Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26465A1 (fr)	2004-12-20	Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26471A1 (fr)	2004-12-20	Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26414A1 (fr)	2004-12-20	Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.
MA26638A1 (fr)	2004-12-20	Derives d'isothiazole nouveaux, procede pour leur preparation et compoositions pharmaceutiques les contenant
MA26438A1 (fr)	2004-12-20	Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26624A1 (fr)	2004-12-20	Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26519A1 (fr)	2004-12-20	Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2751334B1 (fr)	1998-10-16	Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26490A1 (fr)	2004-12-20	Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.